Intrinsic prefrontal functional connectivity according to cognitive impairment in patients with end-stage renal disease

Article information

Kidney Res Clin Pract. 2024;43(6):807-817
Publication date (electronic) : 2023 August 10
doi : https://doi.org/10.23876/j.krcp.22.291
1Department of Neurology, Haeundae Paik Hospital, Inje University College of Medicine, Busan, Republic of Korea
2Department of Internal Medicine, Haeundae Paik Hospital, Inje University College of Medicine, Busan, Republic of Korea
3Department of Internal Medicine, Busan Paik Hospital, Inje University College of Medicine, Busan, Republic of Korea
4YOON’s Clinic of Hemodialysis, Busan, Republic of Korea
Correspondence: Bong Soo Park Department of Internal Medicine, Haeundae Paik Hospital, Inje University College of Medicine, 875 Haeundae-ro, Haeundae-gu, Busan 48108, Republic of Korea. E-mail: h00245@paik.ac.kr
*Kang Min Park and Chang Min Heo contributed equally to this work as co-first authors.
Received 2022 December 20; Revised 2023 March 14; Accepted 2023 March 24.

Abstract

Background

This study aimed to investigate differences in intrinsic prefrontal functional connectivity according to the presence of cognitive impairment in patients with end-stage renal disease (ESRD) using functional near-infrared spectroscopy (fNIRS).

Methods

We prospectively enrolled 37 patients with ESRD who had been undergoing hemodialysis for more than 6 months and had no history of neurological or psychiatric disorders. All patients with ESRD underwent the Korean version of the Montreal Cognitive Assessment (MoCA-K) to assess cognitive function. The NIRSIT Lite device (OBELAB Inc.) was used to acquire fNIRS data, and the NIRSIT Lite Analysis Tool program was used to process the data and generate a functional connectivity matrix. We obtained functional connectivity measures by applying graph theory to the connectivity matrix using the BRAPH (brain analysis using graph theory) program.

Results

Of the 37 patients with ESRD, 23 had cognitive impairment, whereas 14 patients showed no cognitive impairment. Intrinsic prefrontal functional connectivity was significantly different between groups. Network measures of strength, global efficiency, and mean clustering coefficient were lower in ESRD patients with cognitive impairment than in those without cognitive impairment (4.458 vs. 5.129, p = 0.02; 0.397 vs. 0.437, p = 0.03; and 0.316 vs. 0.421, p = 0.003; respectively). There were no significant correlations between MoCA-K scores and clinical characteristics.

Conclusion

We demonstrated a significant association between cognitive function and intrinsic prefrontal functional connectivity in patients with ESRD. ESRD patients with cognitive impairment have reduced connectivity and segregation in the prefrontal brain network compared to those without cognitive impairment.

Graphical abstract

Introduction

Cognitive impairment is commonly observed in patients with end-stage renal disease (ESRD), and ESRD is one of the etiologies of dementia [1]. Although there are differences depending on the subjects or neurocognitive test used, the prevalence of cognitive impairment in patients with ESRD ranges from 16% to 38% [2]. Our previous study reported that approximately 70% of patients with ESRD had cognitive impairment [3]. An interesting result from previous publications is that vascular dementia is more common than Alzheimer dementia in patients with ESRD, and among various cognitive deficits, deterioration of frontal lobe function is particularly evident [4,5].

Two representative methods for screening cognitive function are the Mini-Mental State Examination (MMSE) and the Montreal Cognitive Assessment (MoCA) [6,7]. The MMSE has the advantage of requiring less time for evaluating cognitive function than the MoCA. However, due to its low sensitivity in identifying mild cognitive impairment in patients with a high level of education, the MMSE’s reliability has been questioned [8]. Additionally, it does not indicate declines in attention, executive function, or visuospatial function. The MoCA can assess all cognitive domains and is sensitive to cognitive abnormalities in patients with mild cognitive impairment or dementia, according to multiple studies [9]. Furthermore, the MoCA is more suitable for evaluating the function of the frontal lobe specifically. It assesses a broad range of cognitive domains but predominantly covers executive function items, which is a prominent feature of dementia from vascular causes [4,5]. Therefore, the MoCA is a more appropriate test than the MMSE for cognition evaluation in patients with ESRD. The MoCA is a suitable cognitive screening instrument for patients with ESRD, exhibiting high levels of sensitivity and specificity and covering executive functions, which appear to play a significant role in the cognitive performance of patients with ESRD [10]. A MoCA threshold of 24 points was used to identify patients with cognitive impairment with a sensitivity of 77% and a specificity of 79%, whereas the MMSE discriminated between ESRD patients with and without cognitive impairment only weakly [10]. One study also validated the MoCA, identifying a cutoff of 23.5 points to be more suitable to detect functional cognitive impairment compared to the established value of 26 points, especially in patients with ESRD [11].

Graph theory provides a mathematical framework for modeling and analyzing complex systems [1214]. In neuroscience, graph theory has been utilized to examine the network-level structural and functional organization of the brain. In particular, graph theory can be used to display the brain as a network of nodes and edges, where nodes represent brain regions and edges represent their interconnections. This enables researchers to investigate how information is processed and integrated across different brain regions by analyzing the connectivity patterns of the brain. Graph theory metrics can be utilized to characterize various aspects of brain networks, including their topology, efficiency, and damage resistance. Overall, the application of graph theory to neuroscience has yielded valuable insights into the brain’s complex organization and contributed to our understanding of its function in health and disease [12,13].

Recently, many studies have demonstrated a relationship between cognitive function and functional brain connectivity using the graph theory [15,16]. Several modalities have been used to investigate the functional connectivity of the brain. Resting-state functional magnetic resonance imaging (MRI) is most common, but other modalities such as electroencephalography (EEG), magnetic encephalography, and positron emission tomography also can be utilized [1719]. In addition, functional connectivity can be analyzed using functional near-infrared spectroscopy (fNIRS) [20]. This measures brain tissue concentrations of oxyhemoglobin (HbO2) and deoxyhemoglobin (HbR) and uses blood-oxygen-level-dependent signals to study brain function. The fNIRS does not emit radiation, is noninvasive, and does not harm the human body [2123]. Furthermore, it is fully portable and has the advantage of better temporal resolution than brain MRI and better spatial resolution than EEG [2123]. Moreover, since it is superior in measuring prefrontal functional connectivity, it is an appropriate tool for studying the brain network in patients with ESRD. However, no previous studies have investigated prefrontal functional connectivity in patients with ESRD using fNIRS [2123].

This study aimed to investigate differences in intrinsic prefrontal functional connectivity according to cognitive impairment in patients with ESRD using fNIRS. We hypothesized that there would be significant differences in intrinsic prefrontal functional connectivity between patients with ESRD with and without cognitive impairment.

Methods

This prospective study was approved by the Institutional Review Board of Inje University Haeundae Paik Hospital (No. 2022-06-004-003). The research process was explained to each patient and informed consent was obtained.

Participants: patients with end-stage renal disease

From June 2022 to September 2022, we enrolled 37 patients with ESRD who met the following criteria: 1) were clinically diagnosed with ESRD with a glomerular filtration rate less than 15 mL/min/1.73 m2 requiring renal replacement therapy [24], 2) currently on hemodialysis for more than 6 months, and 3) had no history of diagnosed neurological disorders, including dementia, mild cognitive impairment, stroke, or epilepsy. Laboratory tests also were performed on all patients.

Assessment of cognitive function in patients with end-stage renal disease with a Korean version of the MoCA test

All patients with ESRD underwent a Korean version of the MoCA test (MoCA-K) to assess their cognitive function (Supplementary Fig. 1, available online) [6]. The MoCA test consists of 30 questions and takes approximately 10 minutes to complete. Patients with ESRD were divided into two groups based on the total MoCA test score, with a cutoff value of 23.5 points [11]. Patients with ESRD who scored ≥23.5 points were defined as having normal cognitive function, whereas those with a score of <23.5 points were considered to have cognitive impairment [11].

Evaluation of intrinsic prefrontal functional connectivity in patients with end-stage renal disease with functional near-infrared spectroscopy

Fig. 1 shows the process of obtaining intrinsic prefrontal functional connectivity in ESRD patients. The NIRSIT Lite device (OBELAB Inc.) was used to acquire fNIRS data [25]. The NIRSIT Lite is a wearable, portable, and wireless fNIRS device that measures HbO2 and HbR based on the difference in the near-infrared light absorption rate in real time. Five sources, 13 detectors, and 15 channels were used to detect fNIRS signals in the prefrontal cortex [26]. The system employs two near-infrared wavelengths, 780 nm and 850 nm. The signals were sampled at a rate of 8,138 Hz. All fNIRS acquisitions were performed once before hemodialysis in the dialysis room for 300 seconds, while the patients looked at the tablet PC screen with a white cross on a black background to create the same environment.

Figure 1.

A schematic of the analysis method used for this study.

fNIRS, functional near-infrared spectroscopy.

The NIRSIT Lite Analysis Tool (version 3.2.4) program was used to process fNIRS data and generate a functional connectivity matrix. In the program, we loaded and selected patient information and examined the signal quality and signal-to-noise ratio. Only patients whose signal quality was suitable for analysis were included in this study. We utilized a band-pass filter with a low-pass cutoff frequency of 0.1 Hz and a high-pass cutoff frequency of 0.005 Hz. Each patient’s fNIRS data were processed and exported, and a weighted connectivity matrix was generated for each patient using the Pearson correlation analysis. We then calculated the functional connectivity measures by applying graph theory using the BRAPH (brain analysis using graph theory) program [27] from the connectivity matrix, including the degree, strength, global efficiency, characteristic path length, mean clustering coefficient, and small-worldness index [12,13].

Statistical analysis

We compared the differences in demographic and clinical characteristics, as well as intrinsic prefrontal functional connectivity measures between ESRD patients with and without cognitive impairment using Fisher exact test or the Mann-Whitney test. We used the area under the receiver operating characteristic (ROC) curve (AUC) to investigate the diagnostic predictive value for cognitive impairment with functional connectivity measures. Multivariate logistic regression was also used for analyzing functional connectivity measures in which there were independent variables that determine cognitive impairment in patients with ESRD. The functional connectivity measures were converted into categorical variables by dichotomizing them in accordance with the clear cutoff values with the highest sensitivity and specificity using AUC in the logistic regression analysis. Correlation analysis was conducted using Spearman test. All statistical analyses were conducted using MedCalc Statistical Software version 20.014 (MedCalc Software Ltd.; https://www.medcalc.org; 2021). Statistical p-values lower than 0.05 were considered statistically significant.

Results

Demographic and clinical characteristics in patients with end-stage renal disease

Of the 37 patients with ESRD, 23 (62.2%) had cognitive impairment, whereas 14 (37.8%) showed no cognitive impairment. The median MoCA-K score was 22 (Supplementary Fig. 2, available online). Table 1 shows the differences in the demographic and clinical characteristics of ESRD patients with and without cognitive impairment. There were no significant differences in the demographic data between the groups. However, serum albumin level and intra-dialysis diastolic blood pressure were lower, whereas the low-density lipoprotein level was higher in ESRD patients with cognitive impairment than in those without cognitive impairment.

Demographic and clinical characteristics of ESRD patients with and without cognitive impairment

Intrinsic prefrontal functional connectivity in patients with end-stage renal disease

Table 2 reveals the differences in intrinsic prefrontal functional connectivity between patients with ESRD with and without cognitive impairment. There were significant differences in intrinsic prefrontal functional connectivity between the two groups. The network measures of the strength, global efficiency, and mean clustering coefficient were lower in ESRD patients with cognitive impairment than in those without cognitive impairment (4.458 vs. 5.129, p = 0.02; 0.397 vs. 0.437, p = 0.03; 0.316 vs. 0.421, p = 0.003; respectively). However, the other network measures, including the degree, characteristic path length, and small-worldness index did not vary between ESRD patients with and without cognitive impairment (10.266 vs. 11.066, p = 0.36; 3.182 vs. 2.943, p = 0.16; 0.917 vs. 0.950, p = 0.05; respectively).

Intrinsic prefrontal functional connectivity of end-stage renal disease patients with and without cognitive impairment

Fig. 2 shows the comparison of ROC curves with functional connectivity measures, including the strength (AUC of 0.671), global efficiency (AUC of 0.649), and mean clustering coefficient (AUC of 0.708). The multivariate logistic regression showed that the serum albumin level and mean clustering coefficient were the independent variables that determined the cognitive impairment in patients with ESRD (p = 0.03 and p = 0.048, respectively) (Table 3).

Figure 2.

Comparison of ROC curves.

ROC curves suggest that the mean clustering coefficient (AUC of 0.708) is a more useful measure for predicting cognitive impairment in patients with end-stage renal disease than the other functional connectivity measures, including strength (AUC of 0.671) and global efficiency (AUC of 0.649).

ROC, receiver operating characteristic; AUC, area under the ROC curve.

Results of the multivariate logistic regression for predicting cognitive impairment in patients with end-stage renal disease

Correlation between cognitive function and clinical characteristics in patients with end-stage renal disease

There were no significant correlations between MoCA-K scores and clinical characteristics in patients with ESRD, including dialysis duration, body mass index, dialyzer clearance time/urea distribution volume, ultrafiltration volume, hemoglobin, iron, ferritin, total iron binding capacity, transferrin saturation, albumin, β2-microglobulin, total cholesterol, triglyceride, high-density lipoprotein, low-density lipoprotein, calcium, phosphate, parathyroid hormone, and C-reactive protein (Table 4).

The correlation between cognitive function and clinical characteristics in patients with end-stage renal disease

Discussion

We confirmed the feasibility of using fNIRS to investigate intrinsic prefrontal functional connectivity in patients with ESRD. We also demonstrated significant differences in measures of intrinsic prefrontal functional connectivity between ESRD patients with and without cognitive impairment. Network measures of strength, global efficiency, and mean clustering coefficient were lower in ESRD patients with cognitive impairment than in those without cognitive impairment. Of these network measures, the mean clustering coefficient was the only functional connectivity measure that could determine cognitive impairment in patients with ESRD.

In this study, we found that approximately 62% of patients with ESRD had cognitive impairment despite not having a previous diagnosis of cognitive impairment, including dementia, and being able to participate in normal daily activities. The prevalence of cognitive impairment in patients with ESRD is approximately three times higher than in the age-matched general population [28]; among patients with ESRD, the elderly, women, non-white patients, and those receiving hemodialysis are more susceptible to cognitive impairment [29]. Although the exact pathomechanism for cognitive impairment in patients with ESRD remains unclear, many factors can contribute to impairment of cognitive function, such as anemia, albuminuria, uremic solutes, inflammation, oxidative stress, and intradialytic hypotension, which is related to ESRD treatment [30]. In addition, cerebrovascular disease can play a pivotal role in cognitive impairment in patients with ESRD. A previous study reported that brain MRI in patients with ESRD showed a considerable burden of large vessel stroke, small vessel lacunes, and white matter changes, even without a history of stroke [31]. Furthermore, we recently found that patients with ESRD, as well as those with early chronic kidney disease, had glymphatic system dysfunction, which was demonstrated by diffusion tensor imaging [32,33]. The glymphatic system is a functional glial-dependent system that acts as a scavenger to discharge accumulated waste from the brain, especially during sleep, contributing to improved cognitive functioning. The function of the glymphatic system is reduced in patients with Alzheimer disease [34]. All of these factors can cause cognitive impairment in patients with ESRD, as confirmed in the present study. When we took the cutoff value of MoCA for cognitive impairment as 26 points, approximately 85% of patients with ESRD had cognitive impairment in this study, which was higher than initially expected. This was probably because cognitive function was evaluated using the MoCA. A previous report demonstrated that particularly in elderly patients, the evaluation with the MoCA test was too sensitive in assessing cognitive impairment, and another study also reported that a cutoff value of 26 points was too high to define subjects with normal cognition, especially in the ESRD patient group [10,11]. Thus, in this study, patients with ESRD were divided into patients with and without cognitive impairment using a MoCA score cutoff value of 23.5 points based on previous literature [11].

By applying graph theory to fNIRS data [35], we found that strength, global efficiency, and mean clustering coefficient were lower in ESRD patients with cognitive impairment than in those without cognitive impairment. The degree is the number of edges attached to the nodes, and the weights of these edges indicate the strength [12,13]. Therefore, these results show that ESRD patients with cognitive impairment have fewer edges at the nodes, which means that the connectivity of the brain network is decreased overall. Global efficiency is a graph theory metric that measures the speed with which data can be transferred across a network. Specifically, it quantifies the average length of the shortest inverse path between every pair of network nodes. A greater global efficiency indicates that information can be transmitted quickly and efficiently across the network, enabling more efficient communication between various brain regions, which is related to network integration [12,13]. Integration is the act of bringing together smaller components into a single system that functions as one, which is related to the transfer efficiency of the brain as a whole. Previous studies demonstrated a significant relationship between the cognitive ability and global efficiency of the resting functional network and suggested that high integration underlies performance on tasks with a heavy cognitive load [36]. The authors argued that greater global integration facilitates general cognitive ability, while greater segregation is associated with improved crystallized intelligence, processing speed, and memory benefits from the tendency toward equilibrium [36]. A previous study applying graph theory to EEG data also demonstrated increased characteristic path length in patients with Alzheimer disease [37]. Furthermore, in our previous study, 40 patients with ESRD underwent resting-state functional MRI, and functional connectivity measures were calculated by applying graph theory; the patients exhibited decreased integration of brain network compared to healthy controls, which was consistent with our findings in the current study [3]. Based on the present study, we suggest that cognitive impairment in patients with ESRD is considered a symptom that affects synaptic transmission with an overall functional disconnection, which could be analyzed using a network approach. The clustering coefficient of a node is the proportion of neighboring pairs that are also neighbors. In other words, it measures the degree of connectivity between a node’s neighbors. A high clustering coefficient indicates that the graph’s nodes tend to form dense clusters, whereas a low clustering coefficient indicates that the nodes are more loosely connected, which is related to network segregation [1214]. Thus, decreased global efficiency and mean clustering coefficient in ESRD patients with cognitive impairment indicated that they had a brain network with decreased segregation and integration. In our study, when age and other functional connectivity measures were corrected by logistic regression, only the mean clustering coefficient was found to be a factor predicting cognitive impairment in patients with ESRD. Although there was no difference between the two groups, the characteristic path length is defined as the average number of edges in the shortest paths between all nodes, which is related to the integration of the global brain network [1214]. Small-worldness is a concept in graph theory that describes the equilibrium between local clustering and global connectivity in a network. A small-world network is characterized by a high degree of local clustering and a short average path length. The small-worldness index quantifies the small-world properties of a network and is typically defined as the ratio of normalized clustering coefficient to normalized average path length [1214].

We used fNIRS to investigate functional connectivity in patients with ESRD because it is inexpensive, portable, simple to set up, and radiation-free, making it a safe method [23]. In addition, it has relatively high spatial and temporal resolutions compared to other modalities. It is used to track changes in the activation energy of the superficial layers of the cortex by assessing HbO2 and HbR [38]. In this study, among the various fNIRS devices, we selected the NIRSIT Lite device. Although it can only observe the frontal cortex, patients with ESRD usually have frontal lobe dysfunction, and it is easy to scan without being affected by hair [1,39]. During this study, we were able to confirm that analyzing intrinsic prefrontal functional connectivity using fNIRS was particularly useful for patients with ESRD. Previous studies using fNIRS also showed the significant association between intrinsic prefrontal functional connectivity and cognitive function in various disorders, including traumatic brain injury [40], multiple sclerosis [41], and affective disorders [42], consistent with the findings of our study.

This study had some limitations. First, the sample size was small, especially in the group of patients without cognitive impairment. However, we only enrolled patients with ESRD who had not previously been diagnosed with any psychiatric or neurological disease, and when using the MoCA test, it was more difficult to find patients without cognitive impairment than we initially expected. Second, we only observed intrinsic prefrontal functional connectivity and did not investigate the whole-brain network. However, focusing on intrinsic prefrontal functional connectivity was one of the strengths of this study and is what separates it from previous studies. Third, to maintain the same environment, we obtained fNIRS data for all patients with ESRD before starting hemodialysis. However, it was difficult to rule out the possibility that the dialysis room environment affected the fNIRS results. Lastly, since this was a single-center study, multicenter studies with larger sample sizes should be conducted to confirm our results.

Using fNIRS, we demonstrated a significant association between cognitive function and intrinsic prefrontal functional connectivity in patients with ESRD. ESRD patients with cognitive impairment have reduced connectivity and segregation in the prefrontal brain network compared to those without cognitive impairment.

Notes

Conflicts of interest

All authors have no conflicts of interest to declare.

Funding

This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT) (No. NRF-2022R1F1A1074160).

Data sharing statement

The data presented in this study are available on request from the corresponding author.

Authors’ contributions

Conceptualization: KMP, CMH, BSP

Investigation, Methodology: HJY, BSP

Data curation: DAL, HH, YWK

Formal analysis: SP, YJL

Funding acquisition: YJL

Writing–original draft: KMP, CMH

Writing–review & editing: BSP

All authors read and approved the final manuscript.

Supplementary Materials

Supplementary data are available at Kidney Research and Clinical Practice online (https://doi.org/10.23876/j.krcp.22.291).

References

1. Wilkie M. Vascular dementia–a growing problem in renal disease. Perit Dial Int 2015;35:121–122.
2. Kurella Tamura M, Yaffe K. Dementia and cognitive impairment in ESRD: diagnostic and therapeutic strategies. Kidney Int 2011;79:14–22.
3. Park BS, Kim SE, Lee HJ, et al. Alterations in structural and functional connectivities in patients with end-stage renal disease. J Clin Neurol 2020;16:390–400.
4. Pereira AA, Weiner DE, Scott T, et al. Subcortical cognitive impairment in dialysis patients. Hemodial Int 2007;11:309–314.
5. Kurella Tamura M, Larive B, Unruh ML, et al. Prevalence and correlates of cognitive impairment in hemodialysis patients: the Frequent Hemodialysis Network trials. Clin J Am Soc Nephrol 2010;5:1429–1438.
6. Jung YI, Jeong EH, Lee H, et al. Validation of MoCA-MMSE conversion scales in Korean Patients with cognitive impairments. Dement Neurocogn Disord 2018;17:148–155.
7. Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189–198.
8. Tombaugh TN, McIntyre NJ. The mini-mental state examination: a comprehensive review. J Am Geriatr Soc 1992;40:922–935.
9. Nasreddine ZS, Phillips NA, Bédirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005;53:695–699.
10. Tiffin-Richards FE, Costa AS, Holschbach B, et al. The Montreal Cognitive Assessment (MoCA) - a sensitive screening instrument for detecting cognitive impairment in chronic hemodialysis patients. PLoS One 2014;9e106700.
11. Angermann S, Baumann M, Steubl D, et al. Cognitive impairment in hemodialysis patients: implementation of cut-off values for the Montreal Cognitive Assessment (MoCA)-test for feasible screening. PLoS One 2017;12e0184589.
12. Falsaperla R, Vitaliti G, Marino SD, et al. Graph theory in paediatric epilepsy: a systematic review. Dialogues Clin Neurosci 2021;23:3–13.
13. Farahani FV, Karwowski W, Lighthall NR. Application of graph theory for identifying connectivity patterns in human brain networks: a systematic review. Front Neurosci 2019;13:585.
14. Farid AM, Thompson DJ, Schoonenberg W. A tensor-based formulation of hetero-functional graph theory. Sci Rep 2022;12:18805.
15. Park HR, Cha J, Joo EY, Kim H. Altered cerebrocerebellar functional connectivity in patients with obstructive sleep apnea and its association with cognitive function. Sleep 2022;45:zsab209.
16. Litwińczuk MC, Muhlert N, Cloutman L, Trujillo-Barreto N, Woollams A. Combination of structural and functional connectivity explains unique variation in specific domains of cognitive function. Neuroimage 2022;262:119531.
17. Babaeeghazvini P, Rueda-Delgado LM, Gooijers J, Swinnen SP, Daffertshofer A. Brain structural and functional connectivity: a review of combined works of diffusion magnetic resonance imaging and electro-encephalography. Front Hum Neurosci 2021;15:721206.
18. Dharan AL, Bowden SC, Lai A, et al. Source data from a systematic review and meta-analysis of EEG and MEG studies investigating functional connectivity in idiopathic generalized epilepsy. Data Brief 2021;39:107665.
19. Shim HK, Lee HJ, Kim SE, Lee BI, Park S, Park KM. Alterations in the metabolic networks of temporal lobe epilepsy patients: a graph theoretical analysis using FDG-PET. Neuroimage Clin 2020;27:102349.
20. Chong JS, Chan YL, Ebenezer EGM, et al. fNIRS-based functional connectivity estimation using semi-metric analysis to study decision making by nursing students and registered nurses. Sci Rep 2020;10:22041.
21. Eastmond C, Subedi A, De S, Intes X. Deep learning in fNIRS: a review. Neurophotonics 2022;9:041411.
22. Rahman MA, Siddik AB, Ghosh TK, Khanam F, Ahmad M. A narrative review on clinical applications of fNIRS. J Digit Imaging 2020;33:1167–1184.
23. Lee YJ, Park SY, Sung LY, et al. Reduced left ventrolateral prefrontal cortex activation during verbal fluency tasks is associated with suicidal ideation severity in medication-naïve young adults with major depressive disorder: a functional near-infrared spectroscopy study. Psychiatry Res Neuroimaging 2021;312:111288.
24. Levey AS, Eckardt KU, Dorman NM, et al. Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference. Kidney Int 2020;97:1117–1129.
25. Choi JK, Choi MG, Kim JM, Bae HM. Efficient data extraction method for near-infrared spectroscopy (NIRS) systems with high spatial and temporal resolution. IEEE Trans Biomed Circuits Syst 2013;7:169–177.
26. Kim TJ, Kim JM, Lee JS, et al. Prognostication of neurological outcome after cardiac arrest using wavelet phase coherence analysis of cerebral oxygen. Resuscitation 2020;150:41–49.
27. Mijalkov M, Kakaei E, Pereira JB, Westman E, Volpe G, ; Alzheimer’s Disease Neuroimaging Initiative. BRAPH: a graph theory software for the analysis of brain connectivity. PLoS One 2017;12e0178798.
28. Collins AJ, Kasiske B, Herzog C, et al. Excerpts from the United States Renal Data System 2006 Annual Data Report. Am J Kidney Dis 2007;49A6-A7, S1-S296.
29. Kurella M, Mapes DL, Port FK, Chertow GM. Correlates and outcomes of dementia among dialysis patients: the Dialysis Outcomes and Practice Patterns Study. Nephrol Dial Transplant 2006;21:2543–2548.
30. Sehgal AR, Grey SF, DeOreo PB, Whitehouse PJ. Prevalence, recognition, and implications of mental impairment among hemodialysis patients. Am J Kidney Dis 1997;30:41–49.
31. Ikram MA, Vernooij MW, Hofman A, Niessen WJ, van der Lugt A, Breteler MM. Kidney function is related to cerebral small vessel disease. Stroke 2008;39:55–61.
32. Heo CM, Lee WH, Park BS, et al. Glymphatic dysfunction in patients with end-stage renal disease. Front Neurol 2021;12:809438.
33. Heo CM, Lee DA, Park KM, et al. Glymphatic system dysfunction in patients with early chronic kidney disease. Front Neurol 2022;13:976089.
34. Taoka T, Masutani Y, Kawai H, et al. Evaluation of glymphatic system activity with the diffusion MR technique: diffusion tensor image analysis along the perivascular space (DTI-ALPS) in Alzheimer’s disease cases. Jpn J Radiol 2017;35:172–178.
35. Vecchio F, Miraglia F, Maria Rossini P. Connectome: graph theory application in functional brain network architecture. Clin Neurophysiol Pract 2017;2:206–213.
36. Wang R, Liu M, Cheng X, Wu Y, Hildebrandt A, Zhou C. Segregation, integration, and balance of large-scale resting brain networks configure different cognitive abilities. Proc Natl Acad Sci U S A 2021;118e2022288118.
37. de Haan W, Pijnenburg YA, Strijers RL, et al. Functional neural network analysis in frontotemporal dementia and Alzheimer’s disease using EEG and graph theory. BMC Neurosci 2009;10:101.
38. Yoon JA, Kong IJ, Choi J, et al. Neural compensatory response during complex cognitive function tasks in mild cognitive impairment: a near-infrared spectroscopy study. Neural Plast 2019;2019:7845104.
39. Lee JJ, Chin HJ, Byun MS, et al. Impaired frontal executive function and predialytic chronic kidney disease. J Am Geriatr Soc 2011;59:1628–1635.
40. Skau S, Johansson B, Kuhn HG, Thompson WH. Segregation over time in functional networks in prefrontal cortex for individuals suffering from pathological fatigue after traumatic brain injury. Front Neurosci 2022;16:972720.
41. Gamboa OL, Tagliazucchi E, von Wegner F, et al. Working memory performance of early MS patients correlates inversely with modularity increases in resting state functional connectivity networks. Neuroimage 2014;94:385–395.
42. Zhu H, Xu J, Li J, et al. Decreased functional connectivity and disrupted neural network in the prefrontal cortex of affective disorders: a resting-state fNIRS study. J Affect Disord 2017;221:132–144.

Article information Continued

Figure 1.

A schematic of the analysis method used for this study.

fNIRS, functional near-infrared spectroscopy.

Figure 2.

Comparison of ROC curves.

ROC curves suggest that the mean clustering coefficient (AUC of 0.708) is a more useful measure for predicting cognitive impairment in patients with end-stage renal disease than the other functional connectivity measures, including strength (AUC of 0.671) and global efficiency (AUC of 0.649).

ROC, receiver operating characteristic; AUC, area under the ROC curve.

Table 1.

Demographic and clinical characteristics of ESRD patients with and without cognitive impairment

Characteristic Patients with ESRD Patients with cognitive impairment Patients without cognitive impairment p-value
Demographic data
 No. of patients 37 23 14
 Age (yr) 68.5 (60.0–78.0) 72.0 (58.8–77.0) 68.0 (60.0–78.0) 0.89
 Male sex 25 (67.6) 16 (69.6) 9 (64.3) 0.74
 Dialysis duration (mo) 47.0 (21.5–80.5) 39.0 (17.8–83.5) 52.5 (42.0–65.0) 0.34
 Education (yr) 14.0 (10.5–16.0) 12.0 (12.0–16.0) 16.0 (8.5–16.0) 0.40
 MoCA-K 22.0 (18.5–24.3) 20.0 (15.5–22.0) 25.0 (24.5–27.0) <0.001
 Body mass index (kg/m2) 22.5 (20.2–24.7) 22.5 (20.2–24.2) 22.7 (19.9–25.0) 0.79
 kt/V 1.5 (1.4–1.7) 1.6 (1.5–1.7) 1.5 (1.4–1.7) 0.17
 Ultrafiltration volume (mL) 2,000.0 (1,200.0–2,900.0) 1,900.0 (1,200.0–2,725.0) 2,550.0 (1,500.0–3,000.0) 0.13
 Systolic blood pressure (mmHg)
  Predialysis 150.0 (140.5–160.3) 149.0 (136.0–156.5) 155.0 (145.0–163.0) 0.34
  Intradialysis 146.0 (133.5–153.0) 143.0 (135.2–152.8) 147.0 (128.0–153.0) 0.81
  Postdialysis 151.0 (143.0–160.3) 150.0 (145.0–160.0) 153.5 (130.0–170.0) 0.80
 Diastolic blood pressure (mmHg)
  Predialysis 66.0 (57.5–75.0) 65.0 (56.0–74.8) 71.0 (65.0–75.0) 0.18
  Intradialysis 64.0 (55.5–73.3) 62.0 (53.3–69.3) 72.0 (64.0–74.0) 0.04
  Postdialysis 64.0 (56.7–77.0) 62.0 (53.0–73.8) 70.0 (64.0–82.0) 0.10
 Hypotension episodes during dialysis 0 (0) 0 (0) 0 (0) 0.14
Comorbidity
 Hypertension 35 (94.6) 21 (91.3) 14 (100) 0.26
 Diabetes mellitus 21 (56.8) 12 (52.2) 9 (64.3) 0.48
 Liver disease 2 (5.4) 1 (4.3) 1 (7.1) 0.72
 Heart disease 12 (32.4) 8 (34.8) 4 (28.6) 0.70
Laboratory data
 Hemoglobin (g/dL) 10.6 (9.9–11.1) 10.5 (9.8–11.1) 10.7 (9.9–11.4) 0.40
 Iron (μg/dL) 50.0 (39.8–68.0) 50.0 (38.5–64.3) 55.0 (43.0–72.0) 0.36
 Ferritin (ng/mL) 295.0 (130.3–407.3) 211.0 (147.3–398.5) 296.5 (70.0–423.0) 0.84
 TIBC (μg/dL) 233.0 (210.3–256.0) 233.0 (208.8–251.8) 249.0 (219.0–275.0) 0.26
 Transferrin saturation (%) 23.9 (17.4–29.7) 23.5 (17.2–28.5) 24.9 (18.6–33.3) 0.35
 Albumin (g/dL) 4.0 (3.8–4.4) 3.9 (3.8–4.2) 4.4 (4.0–4.4) 0.01
 β2-microglobulin (mg/dL) 23.8 (18.8–28.1) 23.8 (17.6–28.2) 22.5 (19.5–27.9) 0.94
 Total cholesterol (mg/dL) 128.0 (102.5–158.3) 141.0 (103.0–165.0) 108.0 (100.0–133.0) 0.08
 Triglyceride (mg/dL) 94.0 (68.8–138.5) 86.0 (73.0–137.5) 108.5 (56.0–140.0) 0.99
 HDL-C (mg/dL) 47.0 (37.8–66.3) 47.0 (38.0–61.8) 53.0 (38.0–77.0) 0.58
 LDL-C (mg/dL) 48.4 (36.9–74.6) 62.0 (43.8–79.7) 39.8 (33.6–42.4) 0.009
 Calcium (mg/dL) 8.6 (8.0–9.1) 8.6 (8.0–8.8) 8.5 (8.0–9.3) 0.81
 Phosphate (mg/dL) 5.2 (3.9–6.0) 4.5 (3.2–5.6) 5.7 (4.7–6.3) 0.10
 Parathyroid hormone (pg/mL) 245.0 (160.5–349.5) 226.0 (129.0–366.0) 272.5 (175.0–333.0) 0.72
 C-reactive protein (mg/dL) 0.1 (0.0–0.2) 0.1 (0.0–0.3) 0.1 (0.0–0.1) 0.80

Data are expressed as number only, median (interquartile range), or number (%).

ESRD, end-stage renal disease; HDL-C, high-density lipoprotein-cholesterol; Kt/V, dialyzer clearance time/distribution volume of urea; LDL-C, low-density lipoprotein-cholesterol; MoCA-K, the Korean version of Montreal Cognitive Assessment; TIBC, total iron binding capacity.

Table 2.

Intrinsic prefrontal functional connectivity of end-stage renal disease patients with and without cognitive impairment

Network measure With cognitive impairment (n = 23) Without cognitive impairment (n = 14) p-value
Degree 10.266 (9.433–11.866) 11.066 (9.733–12.266) 0.36
Strength 4.458 (3.722–5.098) 5.129 (4.067–7.540) 0.02*
Global efficiency 0.397 (0.343–0.423) 0.437 (0.365–0.569) 0.03*
Characteristic path length 3.182 (2.918–3.866) 2.943 (2.075–3.927) 0.16
Mean clustering coefficient 0.316 (0.283–0.348) 0.421 (0.302–0.510) 0.003*
Small-worldness index 0.917 (0.878–0.943) 0.950 (0.912–0.978) 0.05

Data are expressed as median (interquartile range).

*

p < 0.05.

Table 3.

Results of the multivariate logistic regression for predicting cognitive impairment in patients with end-stage renal disease

Independent variable Adjusted OR (95% CI) p-value
Age, >62 yr 0.39 (0.01–10.78) 0.59
Male sex 7.50 (0.26–215.69) 0.24
Intradialysis BP, ≤65 mmHg 14.55 (0.55–384.30) 0.11
Albumin, ≤4.2 g/dL 165.05 (1.83–14,878.84) 0.03*
LDL-C, >42.4 mg/dL 6.87 (0.32–144.87) 0.22
Strength, ≤5.825 2.55 (0.04–142.76) 0.65
Global efficiency, ≤0.425 1.12 (0.02–43.02) 0.95
Mean clustering coefficient, ≤0.396 38.70 (1.15–2,444.83) 0.048*

BP, blood pressure; CI, confidence interval; LDL-C, low-density lipoprotein-cholesterol; OR, odds ratio.

*

p < 0.05.

Table 4.

The correlation between cognitive function and clinical characteristics in patients with end-stage renal disease

Clinical characteristic MoCA-K score
r p-value
Dialysis duration –0.035 0.83
Body mass index 0.026 0.88
Dialyzer clearance time/urea distribution volume –0.119 0.48
Ultrafiltration volume 0.219 0.19
Hemoglobin 0.026 0.88
Iron 0.035 0.84
Ferritin –0.091 0.59
Total iron binding capacity 0.199 0.236
Transferrin saturation 0.042 0.81
Albumin 0.063 0.71
β2-microglobulin –0.194 0.25
Total cholesterol –0.245 0.14
Triglyceride –0.143 0.40
High-density lipoprotein –0.006 0.97
Low-density lipoprotein –0.247 0.14
Calcium –0.029 0.87
Phosphate 0.240 0.15
Parathyroid hormone 0.198 0.25
C-reactive protein –0.226 0.18

MoCA-K, the Korean version of Montreal Cognitive Assessment.